Skip to main content
Equibles
ALNY logo

ALNY · Alnylam Pharmaceuticals, Inc. · Documents

Track ALNY — free

Use ALNY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALNY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$232.60 +8.07 (+3.59%) At close · Oct 9
Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$30.04B
Shares
133.81M
Volume · Oct 9 959.95K Avg daily vol (3M) 1.84M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Type Filing Date Period Open
Investor Event Transcript 2026-09-14 2026-09-30
Investor Event Transcript 2026-09-08 2026-09-30
8-K 2026-07-30 —
10-Q 2026-07-30 2026-06-30
Investor Event Transcript 2026-06-09 2026-06-30
8-K 2026-05-27 2026-05-20
Investor Event Transcript 2026-05-13 2026-06-30
10-Q 2026-04-30 2026-03-31
8-K 2026-04-30 —
DEF 14A 2026-04-06 2026-05-20
8-K 2026-03-04 2026-03-02
10-K 2026-02-12 2025-12-31
8-K 2026-02-12 —
8-K 2026-01-12 2026-01-11
8-K 2025-12-11 2025-12-10
8-K 2025-12-03 2025-12-02
8-K 2025-10-30 —
10-Q 2025-10-30 2025-09-30
8-K 2025-10-03 2025-09-30
8-K 2025-09-12 —
8-K 2025-09-10 2025-09-08
8-K 2025-07-31 —
10-Q 2025-07-31 2025-06-30
8-K 2025-06-18 2025-06-12
8-K 2025-05-13 2025-05-08
8-K 2025-05-01 —
10-Q 2025-05-01 2025-03-31
DEF 14A 2025-03-24 2025-05-08
8-K 2025-03-21 2025-03-20
8-K 2025-03-05 2025-03-03
8-K 2025-02-13 —
10-K 2025-02-13 2024-12-31
8-K 2025-01-13 2025-01-12
8-K 2024-10-31 —
10-Q 2024-10-31 2024-09-30
8-K 2024-08-01 —
10-Q 2024-08-01 2024-06-30
8-K 2024-05-20 2024-05-16
8-K 2024-05-02 —
10-Q 2024-05-02 2024-03-31
DEF 14A 2024-04-01 2024-05-16
8-K 2024-03-04 —
10-K 2024-02-15 2023-12-31
8-K 2024-02-15 —
8-K 2024-01-19 2024-01-12
8-K 2024-01-08 2024-01-07
8-K 2023-11-02 —
10-Q 2023-11-02 2023-09-30
8-K 2023-10-10 2023-10-09
8-K 2023-09-28 2023-09-26
Showing 1–50 of 112 filings
Key facts CIK 1178670 CUSIP 02043Q107 13F (30d) 32 filings 28 filers Visit website Investor relations